Translated automatically – community improvements welcome.
Trihexyphenidyl
Trihexyphenidyl is a centrally acting anticholinergic agent primarily used for the treatment of Parkinson's symptoms. It blocks muscarinic acetylcholine receptors and thereby exerts spasmolytic and antiparkinsonian effects. Side effects may include anticholinergic effects such as dry mouth, cognitive impairments, and tachycardia. Due to its pharmacological profile, improper use may lead to cognitive disturbances and delirium.
Mechanism of Action
- Muscarinic antagonist
Names / Identifiers
IUPAC: Trihexyphenidyl
Mechanism of Action
Trihexyphenidyl wirkt als Antagonist an muskarinischen Acetylcholinrezeptoren, was zu einer Reduktion der cholinergen Aktivität im zentralen Nervensystem führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Glaucoma
- Prostate hyperplasia
- Myasthenia gravis
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Mundtrockenheit, Schwindel und Verwirrtheit.
Safer Use
- Start at a low dose.
- Consider regular medical monitoring.
Harm reduction tips do not replace medical advice.
Known Interactions
- May interact with other anticholinergics.
- Caution with concurrent alcohol consumption.
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.